AXIM released manuscript describing rapid point-of-care test that measures COVID-19 neutralizing antibodies

, ,

On Jan. 11, 2021, AXIM Biotechnologies announced that it had released a preprint of its manuscript describing the development of ImmunoPass, the Company’s rapid point-of-care test that semi-quantitatively measures levels of neutralizing antibodies to COVID-19.

Tags:

,

Source: AXIM Biotechnologies
Credit:

Visit News/History Source
bioinnovatise accelerates scientific discovery by providing fast, reliable, and high-quality CDMO services for plasmid DNA and viral vector-based research.